AAAAAA
Results:
1-20
|
Results: 20
Authors:
Zegels, B
Eastell, R
Russell, RGG
Ethgen, D
Roumagnac, I
Collette, J
Reginster, JY
Citation: B. Zegels et al., Effect of high doses of oral risedronate (20 mg/day) on serum parathyroid hormone levels and urinary collagen cross-link excretion in postmenopausal women with spinal osteoporosis, BONE, 28(1), 2001, pp. 108-112
Authors:
Eastell, R
Reid, DM
Compston, J
Cooper, C
Fogelman, I
Francis, RM
Hay, SM
Hosking, DJ
Purdie, DW
Ralston, SH
Reeve, J
Russell, RGG
Stevenson, JC
Citation: R. Eastell et al., Secondary prevention of osteoporosis: when should a non-vertebral fracturebe a trigger for action?, QJM-MON J A, 94(11), 2001, pp. 575-597
Authors:
Edwards, CJ
Russell, RGG
Spector, TD
Citation: Cj. Edwards et al., Statins and bone: Myth or reality?, CALCIF TIS, 69(2), 2001, pp. 63-66
Authors:
Eastell, R
Devogelaer, JP
Peel, NFA
Chines, AA
Bax, DE
Sacco-Gibson, N
de Deuxchaisnes, CN
Russell, RGG
Citation: R. Eastell et al., Prevention of bone loss with risedronate in glucocorticoid-treated rheumatoid arthritis patients, OSTEOPOR IN, 11(4), 2000, pp. 331-337
Authors:
Croucher, LJ
Crawford, A
Hatton, PV
Russell, RGG
Buttle, DJ
Citation: Lj. Croucher et al., Extracellular ATP and UTP stimulate cartilage proteoglycan and collagen accumulation in bovine articular chondrocyte pellet cultures, BBA-MOL BAS, 1502(2), 2000, pp. 297-306
Authors:
Shipman, CM
Rogers, MJ
Vanderkerken, K
Van Camp, B
Russell, RGG
Croucher, PI
Citation: Cm. Shipman et al., Bisphosphonates - Mechanisms of action in multiple myeloma, ACTA ONCOL, 39(7), 2000, pp. 829-835
Authors:
Shipman, CM
Vanderkerken, K
Rogers, MJ
Lippitt, JM
Asosingh, K
Hughes, DE
Van Camp, B
Russell, RGG
Croucher, PI
Citation: Cm. Shipman et al., The potent bisphosphonate ibandronate does not induce myeloma cell apoptosis in a murine model of established multiple myeloma, BR J HAEM, 111(1), 2000, pp. 283-286
Authors:
Karadag, A
Oyajobi, BO
Apperley, JF
Russell, RGG
Croucher, PI
Citation: A. Karadag et al., Human myeloma cells promote the production of interleukin 6 by primary human osteoblasts, BR J HAEM, 108(2), 2000, pp. 383-390
Authors:
Russell, RGG
Rogers, MJ
Citation: Rgg. Russell et Mj. Rogers, Bisphosphonates: From the laboratory to the clinic and back again, BONE, 25(1), 1999, pp. 97-106
Authors:
Rogers, MJ
Frith, JC
Luckman, SP
Coxon, FP
Benford, HL
Monkkonen, J
Auriola, S
Chilton, KM
Russell, RGG
Citation: Mj. Rogers et al., Molecular mechanisms of action of bisphosphonates, BONE, 24(5), 1999, pp. 73S-79S
Authors:
Russell, RGG
Citation: Rgg. Russell, The bisphosphonate odyssey. A journey from chemistry to the clinic, PHOSPHOR SU, 146, 1999, pp. 793-820
Authors:
Russell, RGG
Croucher, PI
Rogers, MJ
Citation: Rgg. Russell et al., Bisphosphonates: Pharmacology, mechanisms of action and clinical uses, OSTEOPOR IN, 9, 1999, pp. 66-80
Authors:
Russell, RGG
Rogers, MJ
Frith, JC
Luckman, SP
Coxon, FP
Benford, HL
Croucher, PI
Shipman, C
Fleisch, HA
Citation: Rgg. Russell et al., The pharmacology of bisphosphonates and new insights into their mechanismsof action, J BONE MIN, 14, 1999, pp. 53-65
Authors:
Qi, DY
Perkins, SL
Kling, SJ
Russell, RGG
Citation: Dy. Qi et al., Divergent regulation of 1,25-dihydroxyvitamin D-3 on human bone marrow osteoclastogenesis and myelopoiesis, J CELL BIOC, 72(3), 1999, pp. 387-395
Authors:
Liu, P
Oyajobi, BO
Russell, RGG
Scutt, A
Citation: P. Liu et al., Regulation of osteogenic differentiation of human bone marrow stromal cells: Interaction between transforming growth factor-beta and 1,25(OH)(2) vitamin D-3 in vitro, CALCIF TIS, 65(2), 1999, pp. 173-180
Authors:
Fisher, JE
Rogers, MJ
Halasy, JM
Luckman, SP
Hughes, DE
Masarachia, PJ
Wesolowski, G
Russell, RGG
Rodan, GA
Reszka, AA
Citation: Je. Fisher et al., Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro, P NAS US, 96(1), 1999, pp. 133-138
Authors:
Lehane, DB
McKie, N
Russell, RGG
Henderson, IW
Citation: Db. Lehane et al., Cloning of a fragment of the osteonectin gene from goldfish, Carassius auratus: Its expression and potential regulation by estrogen, GEN C ENDOC, 114(1), 1999, pp. 80-87
Authors:
Sati, HIA
Greaves, M
Apperley, JF
Russell, RGG
Croucher, PI
Citation: Hia. Sati et al., Expression of interleukin-1 beta and tumour necrosis factor-alpha in plasma cells from patients with multiple myeloma, BR J HAEM, 104(2), 1999, pp. 350-357
Authors:
Shipman, CM
Rogers, MJ
Apperley, JF
Russell, RGG
Croucher, PI
Citation: Cm. Shipman et al., Anti-tumour activity of bisphosphonates in human myeloma cells, LEUK LYMPH, 32(1-2), 1998, pp. 129-138
Authors:
Shipman, CM
Croucher, PI
Russell, RGG
Helfrich, MH
Rogers, MJ
Citation: Cm. Shipman et al., The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway, CANCER RES, 58(23), 1998, pp. 5294-5297
Risultati:
1-20
|